Publications by authors named "Angela Mislowsky"

Claim this Profile
C
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul, Angela Mislowsky

Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky

JCO Precis Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Peter Beitsch, Pat Whitworth, Paul Baron, Michael C Rotkis, Angela M Mislowsky

Ann Surg Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
Pat Whitworth, Peter Beitsch, Angela Mislowsky, James V Pellicane, Charles Nash

Ann Surg Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy.
Paul Baron, Peter Beitsch, Danielle Boselli, James Symanowski, James V Pellicane, Angela Mislowsky

Ann Surg Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, Paul Richards, Michael Rotkis, Angela Mislowsky

Ann Surg Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.
Angela Mislowsky, Susan Domchek, Cecilia Stroede, Meredith R Bergey, Seema S Sonnad

Ann Surg Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis